25 XP   0   0   10

Avecho Biotechnology Ltd
Buy, Hold or Sell?

Let's analyse Avecho together

PenkeI guess you are interested in Avecho Biotechnology Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Avecho Biotechnology Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Avecho Biotechnology Ltd

I send you an email if I find something interesting about Avecho Biotechnology Ltd.

Quick analysis of Avecho (30 sec.)










What can you expect buying and holding a share of Avecho? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.01
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
99.8%

For what price can you sell your share?

Current Price per Share
A$0.01
Expected price per share
A$0.004 - A$0.005
How sure are you?
50%

1. Valuation of Avecho (5 min.)




Live pricePrice per Share (EOD)

A$0.01

Intrinsic Value Per Share

A$-0.02 - A$0.00

Total Value Per Share

A$-0.01 - A$0.01

2. Growth of Avecho (5 min.)




Is Avecho growing?

Current yearPrevious yearGrowGrow %
How rich?$4.1m$1.5m$2.5m62.0%

How much money is Avecho making?

Current yearPrevious yearGrowGrow %
Making money-$2.2m-$1.5m-$705.9k-31.8%
Net Profit Margin-725.7%-207.4%--

How much money comes from the company's main activities?

3. Financial Health of Avecho (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#766 / 1009

Most Revenue
#573 / 1009

Most Profit
#315 / 1009

Most Efficient
#777 / 1009

What can you expect buying and holding a share of Avecho? (5 min.)

Welcome investor! Avecho's management wants to use your money to grow the business. In return you get a share of Avecho.

What can you expect buying and holding a share of Avecho?

First you should know what it really means to hold a share of Avecho. And how you can make/lose money.

Speculation

The Price per Share of Avecho is A$0.005. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Avecho.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Avecho, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Avecho.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-14.0%0.00-14.0%0.00-9.5%0.00-8.9%0.00-28.5%
Usd Book Value Change Per Share0.0016.1%0.0016.1%0.00-8.6%0.002.0%0.00-14.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.003.6%0.001.8%
Usd Total Gains Per Share0.0016.1%0.0016.1%0.00-8.6%0.005.6%0.00-12.2%
Usd Price Per Share0.00-0.00-0.01-0.01-0.01-
Price to Earnings Ratio-3.23--3.23--20.30--11.48--10.19-
Price-to-Total Gains Ratio2.81-2.81--22.51--8.21--3.67-
Price to Book Ratio1.74-1.74-19.60-13.82-9.61-
Price-to-Total Gains Ratio2.81-2.81--22.51--8.21--3.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.003226
Number of shares309981
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (309981 shares)249.4586.80
Gains per Year (309981 shares)997.79347.19
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10998988222125337
2019961986444250684
30299329846663751031
40399139828885001378
504989498011106251725
605987597813337512072
706985697615558762419
8079827974177710012766
9089808972199911263113
10099789970222112513460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.09.00.010.0%5.026.00.016.1%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%4.06.00.040.0%14.016.01.045.2%
Dividend per Share0.00.01.00.0%1.00.02.033.3%1.00.04.020.0%1.00.09.010.0%5.00.026.016.1%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%4.06.00.040.0%15.016.00.048.4%

Fundamentals of Avecho

About Avecho Biotechnology Ltd

Avecho Biotechnology Limited, a biotechnology company, engages in the development and commercialization of human and animal health related products using its proprietary drug delivery system and Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. In addition, the company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. Further, it develops feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney for treatment of osteoarthritis. The company was incorporated in 1992 and is based in Clayton, Australia.

Fundamental data was last updated by Penke on 2024-04-19 09:11:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Avecho Biotechnology Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Avecho earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avecho to the Biotechnology industry mean.
  • A Net Profit Margin of -725.7% means that $-7.26 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avecho Biotechnology Ltd:

  • The MRQ is -725.7%. The company is making a huge loss. -2
  • The TTM is -725.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-725.7%TTM-725.7%0.0%
TTM-725.7%YOY-207.4%-518.3%
TTM-725.7%5Y-407.9%-317.8%
5Y-407.9%10Y-554.5%+146.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-725.7%-200.1%-525.6%
TTM-725.7%-216.8%-508.9%
YOY-207.4%-288.3%+80.9%
5Y-407.9%-449.1%+41.2%
10Y-554.5%-605.5%+51.0%
1.1.2. Return on Assets

Shows how efficient Avecho is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avecho to the Biotechnology industry mean.
  • -47.0% Return on Assets means that Avecho generated $-0.47 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avecho Biotechnology Ltd:

  • The MRQ is -47.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -47.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-47.0%TTM-47.0%0.0%
TTM-47.0%YOY-70.0%+23.1%
TTM-47.0%5Y-50.7%+3.7%
5Y-50.7%10Y-65.3%+14.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-47.0%-13.3%-33.7%
TTM-47.0%-12.8%-34.2%
YOY-70.0%-11.7%-58.3%
5Y-50.7%-13.9%-36.8%
10Y-65.3%-15.7%-49.6%
1.1.3. Return on Equity

Shows how efficient Avecho is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avecho to the Biotechnology industry mean.
  • -53.9% Return on Equity means Avecho generated $-0.54 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avecho Biotechnology Ltd:

  • The MRQ is -53.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -53.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-53.9%TTM-53.9%0.0%
TTM-53.9%YOY-96.6%+42.7%
TTM-53.9%5Y-63.4%+9.5%
5Y-63.4%10Y-78.9%+15.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-53.9%-16.9%-37.0%
TTM-53.9%-16.1%-37.8%
YOY-96.6%-15.1%-81.5%
5Y-63.4%-19.3%-44.1%
10Y-78.9%-20.2%-58.7%

1.2. Operating Efficiency of Avecho Biotechnology Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Avecho is operating .

  • Measures how much profit Avecho makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avecho to the Biotechnology industry mean.
  • An Operating Margin of -969.1% means the company generated $-9.69  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avecho Biotechnology Ltd:

  • The MRQ is -969.1%. The company is operating very inefficient. -2
  • The TTM is -969.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-969.1%TTM-969.1%0.0%
TTM-969.1%YOY-206.9%-762.2%
TTM-969.1%5Y-521.4%-447.7%
5Y-521.4%10Y-487.8%-33.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-969.1%-296.2%-672.9%
TTM-969.1%-232.5%-736.6%
YOY-206.9%-298.2%+91.3%
5Y-521.4%-492.1%-29.3%
10Y-487.8%-632.4%+144.6%
1.2.2. Operating Ratio

Measures how efficient Avecho is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 10.69 means that the operating costs are $10.69 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avecho Biotechnology Ltd:

  • The MRQ is 10.691. The company is inefficient in keeping operating costs low. -1
  • The TTM is 10.691. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ10.691TTM10.6910.000
TTM10.691YOY3.713+6.978
TTM10.6915Y6.365+4.326
5Y6.36510Y6.982-0.616
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.6913.231+7.460
TTM10.6913.310+7.381
YOY3.7133.890-0.177
5Y6.3655.739+0.626
10Y6.9827.876-0.894

1.3. Liquidity of Avecho Biotechnology Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Avecho is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.30 means the company has $8.30 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avecho Biotechnology Ltd:

  • The MRQ is 8.305. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.305. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.305TTM8.3050.000
TTM8.305YOY3.825+4.480
TTM8.3055Y6.270+2.035
5Y6.27010Y6.988-0.718
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.3053.890+4.415
TTM8.3054.173+4.132
YOY3.8255.344-1.519
5Y6.2706.126+0.144
10Y6.9886.448+0.540
1.3.2. Quick Ratio

Measures if Avecho is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avecho to the Biotechnology industry mean.
  • A Quick Ratio of 7.83 means the company can pay off $7.83 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avecho Biotechnology Ltd:

  • The MRQ is 7.831. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.831. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.831TTM7.8310.000
TTM7.831YOY3.085+4.746
TTM7.8315Y5.681+2.150
5Y5.68110Y6.515-0.834
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.8313.514+4.317
TTM7.8313.998+3.833
YOY3.0855.380-2.295
5Y5.6816.105-0.424
10Y6.5156.404+0.111

1.4. Solvency of Avecho Biotechnology Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Avecho assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avecho to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.13 means that Avecho assets are financed with 12.9% credit (debt) and the remaining percentage (100% - 12.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Avecho Biotechnology Ltd:

  • The MRQ is 0.129. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.129. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.129TTM0.1290.000
TTM0.129YOY0.275-0.147
TTM0.1295Y0.170-0.042
5Y0.17010Y0.149+0.022
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1290.339-0.210
TTM0.1290.336-0.207
YOY0.2750.271+0.004
5Y0.1700.366-0.196
10Y0.1490.389-0.240
1.4.2. Debt to Equity Ratio

Measures if Avecho is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avecho to the Biotechnology industry mean.
  • A Debt to Equity ratio of 14.8% means that company has $0.15 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avecho Biotechnology Ltd:

  • The MRQ is 0.148. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.148. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.148TTM0.1480.000
TTM0.148YOY0.380-0.232
TTM0.1485Y0.213-0.065
5Y0.21310Y0.183+0.030
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1480.388-0.240
TTM0.1480.402-0.254
YOY0.3800.335+0.045
5Y0.2130.426-0.213
10Y0.1830.461-0.278

2. Market Valuation of Avecho Biotechnology Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avecho generates.

  • Above 15 is considered overpriced but always compare Avecho to the Biotechnology industry mean.
  • A PE ratio of -3.23 means the investor is paying $-3.23 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avecho Biotechnology Ltd:

  • The EOD is -4.611. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.228. Based on the earnings, the company is expensive. -2
  • The TTM is -3.228. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.611MRQ-3.228-1.383
MRQ-3.228TTM-3.2280.000
TTM-3.228YOY-20.295+17.067
TTM-3.2285Y-11.481+8.253
5Y-11.48110Y-10.185-1.296
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.611-2.264-2.347
MRQ-3.228-2.629-0.599
TTM-3.228-2.680-0.548
YOY-20.295-4.145-16.150
5Y-11.481-6.257-5.224
10Y-10.185-6.254-3.931
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Avecho Biotechnology Ltd:

  • The EOD is -4.983. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.488. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.488. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.983MRQ-3.488-1.495
MRQ-3.488TTM-3.4880.000
TTM-3.488YOY-27.666+24.178
TTM-3.4885Y-19.848+16.359
5Y-19.84810Y-16.859-2.988
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.983-2.973-2.010
MRQ-3.488-3.333-0.155
TTM-3.488-3.553+0.065
YOY-27.666-5.605-22.061
5Y-19.848-8.376-11.472
10Y-16.859-8.865-7.994
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Avecho is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.74 means the investor is paying $1.74 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Avecho Biotechnology Ltd:

  • The EOD is 2.485. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.739. Based on the equity, the company is underpriced. +1
  • The TTM is 1.739. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.485MRQ1.739+0.745
MRQ1.739TTM1.7390.000
TTM1.739YOY19.605-17.866
TTM1.7395Y13.822-12.083
5Y13.82210Y9.614+4.209
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.4851.896+0.589
MRQ1.7392.115-0.376
TTM1.7392.093-0.354
YOY19.6052.884+16.721
5Y13.8223.542+10.280
10Y9.6143.916+5.698
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Avecho Biotechnology Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Avecho Biotechnology Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0010.0010%-0.001+153%0.000+698%-0.001+187%
Book Value Per Share--0.0020.0020%0.001+163%0.001+54%0.004-47%
Current Ratio--8.3058.3050%3.825+117%6.270+32%6.988+19%
Debt To Asset Ratio--0.1290.1290%0.275-53%0.170-25%0.149-13%
Debt To Equity Ratio--0.1480.1480%0.380-61%0.213-31%0.183-19%
Dividend Per Share----0%-0%0.000-100%0.000-100%
Eps---0.001-0.0010%-0.001-32%-0.001-36%-0.002+103%
Free Cash Flow Per Share---0.001-0.0010%-0.001-46%-0.001-47%-0.001+23%
Free Cash Flow To Equity Per Share--0.0010.0010%-0.001+145%0.000+527%0.000+2520%
Gross Profit Margin--1.2411.2410%1.025+21%1.219+2%1.110+12%
Intrinsic Value_10Y_max--0.003--------
Intrinsic Value_10Y_min---0.016--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min---0.001--------
Intrinsic Value_3Y_max---0.001--------
Intrinsic Value_3Y_min---0.004--------
Intrinsic Value_5Y_max--0.000--------
Intrinsic Value_5Y_min---0.007--------
Market Cap15846499.840+30%11092549.88811092549.8880%47539499.520-77%42151689.574-74%65129114.342-83%
Net Profit Margin---7.257-7.2570%-2.074-71%-4.079-44%-5.545-24%
Operating Margin---9.691-9.6910%-2.069-79%-5.214-46%-4.878-50%
Operating Ratio--10.69110.6910%3.713+188%6.365+68%6.982+53%
Pb Ratio2.485+30%1.7391.7390%19.605-91%13.822-87%9.614-82%
Pe Ratio-4.611-43%-3.228-3.2280%-20.295+529%-11.481+256%-10.185+216%
Price Per Share0.005+30%0.0040.0040%0.015-77%0.013-74%0.021-83%
Price To Free Cash Flow Ratio-4.983-43%-3.488-3.4880%-27.666+693%-19.848+469%-16.859+383%
Price To Total Gains Ratio4.009+30%2.8062.8060%-22.512+902%-8.211+393%-3.669+231%
Quick Ratio--7.8317.8310%3.085+154%5.681+38%6.515+20%
Return On Assets---0.470-0.4700%-0.700+49%-0.507+8%-0.653+39%
Return On Equity---0.539-0.5390%-0.966+79%-0.634+18%-0.789+46%
Total Gains Per Share--0.0010.0010%-0.001+153%0.000+187%-0.001+176%
Usd Book Value--4114937.2044114937.2040%1564542.899+163%2677918.988+54%7784905.453-47%
Usd Book Value Change Per Share--0.0010.0010%0.000+153%0.000+698%-0.001+187%
Usd Book Value Per Share--0.0010.0010%0.000+163%0.001+54%0.002-47%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps---0.001-0.0010%0.000-32%0.000-36%-0.001+103%
Usd Free Cash Flow---2051706.966-2051706.9660%-1108667.161-46%-1089005.982-47%-2529554.022+23%
Usd Free Cash Flow Per Share---0.001-0.0010%0.000-46%0.000-47%-0.001+23%
Usd Free Cash Flow To Equity Per Share--0.0010.0010%0.000+145%0.000+527%0.000+2520%
Usd Market Cap10224161.697+30%7156913.1887156913.1880%30672485.090-77%27196270.113-74%42021304.574-83%
Usd Price Per Share0.003+30%0.0020.0020%0.010-77%0.009-74%0.013-83%
Usd Profit---2217269.157-2217269.1570%-1511310.673-32%-1477498.580-33%-4539324.279+105%
Usd Revenue--305535.105305535.1050%728598.552-58%905751.245-66%984112.140-69%
Usd Total Gains Per Share--0.0010.0010%0.000+153%0.000+187%-0.001+176%
 EOD+6 -2MRQTTM+0 -0YOY+19 -155Y+19 -1710Y+22 -14

4.2. Fundamental Score

Let's check the fundamental score of Avecho Biotechnology Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.611
Price to Book Ratio (EOD)Between0-12.485
Net Profit Margin (MRQ)Greater than0-7.257
Operating Margin (MRQ)Greater than0-9.691
Quick Ratio (MRQ)Greater than17.831
Current Ratio (MRQ)Greater than18.305
Debt to Asset Ratio (MRQ)Less than10.129
Debt to Equity Ratio (MRQ)Less than10.148
Return on Equity (MRQ)Greater than0.15-0.539
Return on Assets (MRQ)Greater than0.05-0.470
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Avecho Biotechnology Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.829
Ma 20Greater thanMa 500.004
Ma 50Greater thanMa 1000.004
Ma 100Greater thanMa 2000.004
OpenGreater thanClose0.004
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Net Interest Income  -3-2-5-10-1513-22220



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets7,319
Total Liabilities942
Total Stockholder Equity6,378
 As reported
Total Liabilities 942
Total Stockholder Equity+ 6,378
Total Assets = 7,319

Assets

Total Assets7,319
Total Current Assets7,004
Long-term Assets316
Total Current Assets
Cash And Cash Equivalents 5,504
Net Receivables 1,100
Inventory 97
Other Current Assets 303
Total Current Assets  (as reported)7,004
Total Current Assets  (calculated)7,004
+/-0
Long-term Assets
Property Plant Equipment 316
Long-term Assets Other 0
Long-term Assets  (as reported)316
Long-term Assets  (calculated)316
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities843
Long-term Liabilities98
Total Stockholder Equity6,378
Total Current Liabilities
Short-term Debt 77
Accounts payable 95
Other Current Liabilities 513
Total Current Liabilities  (as reported)843
Total Current Liabilities  (calculated)685
+/- 158
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt98
Long-term Liabilities  (as reported)98
Long-term Liabilities  (calculated)98
+/-0
Total Stockholder Equity
Common Stock244,606
Retained Earnings -239,628
Accumulated Other Comprehensive Income 1,400
Total Stockholder Equity (as reported)6,378
Total Stockholder Equity (calculated)6,378
+/-0
Other
Capital Stock244,606
Cash and Short Term Investments 5,504
Common Stock Shares Outstanding 2,268,084
Current Deferred Revenue158
Liabilities and Stockholders Equity 7,319
Net Debt -5,329
Net Invested Capital 6,378
Net Working Capital 6,160
Property Plant and Equipment Gross 316
Short Long Term Debt Total 175



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-31
> Total Assets 
11,875
11,193
34,482
0
5,522
1,620
5,096
20,860
18,397
14,839
29,408
114,034
171,072
173,494
171,521
69,189
67,364
53,768
76,577
64,121
42,958
50,901
30,744
13,354
8,240
4,802
5,315
3,355
5,246
3,346
7,319
7,3193,3465,2463,3555,3154,8028,24013,35430,74450,90142,95864,12176,57753,76867,36469,189171,521173,494171,072114,03429,40814,83918,39720,8605,0961,6205,522034,48211,19311,875
   > Total Current Assets 
11,875
1,749
111
0
17
281
2,277
4,665
3,559
2,250
2,424
7,934
14,648
16,026
12,371
13,510
11,547
3,724
30,759
23,117
14,155
27,056
17,956
10,183
5,802
3,247
4,278
2,691
4,808
2,851
7,004
7,0042,8514,8082,6914,2783,2475,80210,18317,95627,05614,15523,11730,7593,72411,54713,51012,37116,02614,6487,9342,4242,2503,5594,6652,2772811701111,74911,875
       Cash And Cash Equivalents 
147
296
81
183
1
153
2,236
4,232
3,284
2,196
2,312
7,222
13,189
14,425
10,715
12,896
10,868
2,740
27,196
16,912
8,823
20,679
12,395
6,092
2,899
2,111
3,211
1,873
3,265
1,468
5,504
5,5041,4683,2651,8733,2112,1112,8996,09212,39520,6798,82316,91227,1962,74010,86812,89610,71514,42513,1897,2222,3122,1963,2844,2322,236153118381296147
       Short-term Investments 
10,038
0
0
0
0
0
29
400
240
0
14
0
0
0
0
0
0
0
0
0
0
0
0
205
455
57
0
0
0
86
0
08600057455205000000000000140240400290000010,038
       Net Receivables 
1,674
1,453
30
189
13
128
12
33
35
31
66
660
1,003
1,498
1,577
232
292
305
2,376
4,993
4,421
5,213
4,724
3,607
2,395
677
755
479
1,127
746
1,100
1,1007461,1274797556772,3953,6074,7245,2134,4214,9932,3763052922321,5771,4981,003660663135331212813189301,4531,674
       Other Current Assets 
16
0
0
0
3
0
0
0
0
22
32
45
0
0
0
0
0
157
223
358
212
562
542
247
218
359
163
239
219
235
303
303235219239163359218247542562212358223157000004532220000300016
   > Long-term Assets 
0
9,444
34,371
0
5,505
1,339
2,819
16,195
14,838
12,589
26,985
106,099
156,424
157,468
159,150
55,679
55,817
50,044
45,818
41,004
28,803
23,845
12,788
3,171
2,437
1,555
1,037
664
438
494
316
3164944386641,0371,5552,4373,17112,78823,84528,80341,00445,81850,04455,81755,679159,150157,468156,424106,09926,98512,58914,83816,1952,8191,3395,505034,3719,4440
       Property Plant Equipment 
0
0
0
0
0
0
19
167
143
120
96
280
611
1,023
1,902
3,617
3,755
2,767
2,563
2,370
2,196
814
519
385
251
160
180
233
336
468
316
3164683362331801602513855198142,1962,3702,5632,7673,7553,6171,9021,0236112809612014316719000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
34,261
34,261
34,261
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000034,26134,26134,261000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
105,820
121,552
122,184
122,987
52,062
52,062
45,577
43,255
38,634
26,607
23,031
12,269
2,786
2,186
1,395
857
431
102
26
0
0261024318571,3952,1862,78612,26923,03126,60738,63443,25545,57752,06252,062122,987122,184121,552105,82000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000
> Total Liabilities 
1,459
380
5,579
0
73
33
72
185
56
30
25
811
38,935
38,020
37,759
17,636
17,375
14,761
3,631
1,509
2,187
1,873
1,816
1,707
1,836
902
556
700
709
921
942
9429217097005569021,8361,7071,8161,8732,1871,5093,63114,76117,37517,63637,75938,02038,93581125305618572337305,5793801,459
   > Total Current Liabilities 
763
92
2,168
0
73
33
72
185
56
30
25
811
38,935
1,102
841
1,508
1,247
931
3,602
1,453
2,120
1,778
1,781
1,663
1,714
873
545
604
696
746
843
8437466966045458731,7141,6631,7811,7782,1201,4533,6029311,2471,5088411,10238,93581125305618572337302,16892763
       Short-term Debt 
10,038
0
0
0
0
0
29
400
240
0
14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89
73
80
71
77
7771807389000000000000000140240400290000010,038
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
409
572
1,080
132
97
110
75
191
95
9519175110971321,0805724090000000000000000000000
       Other Current Liabilities 
-9,275
92
2,168
11
73
33
35
-277
-201
0
0
0
356
0
0
0
0
0
0
0
0
0
261
221
525
740
359
420
540
483
513
513483540420359740525221261000000000356000-201-277353373112,16892-9,275
   > Long-term Liabilities 
696
288
3,411
0
0
0
0
0
0
0
0
0
0
36,918
36,918
16,128
16,128
13,830
29
56
67
95
35
44
123
30
11
97
14
175
98
981751497113012344359567562913,83016,12816,12836,91836,91800000000003,411288696
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
93
14
175
0
01751493800000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35
44
123
30
4
3
0
0
0
000343012344350000000000000000000000
> Total Stockholder Equity
10,416
10,813
28,903
0
5,449
1,587
5,024
20,675
18,341
14,808
29,383
113,223
132,184
135,474
133,762
51,553
49,989
39,007
72,946
62,612
40,771
49,028
28,928
11,647
6,403
3,900
4,759
2,654
4,537
2,425
6,378
6,3782,4254,5372,6544,7593,9006,40311,64728,92849,02840,77162,61272,94639,00749,98951,553133,762135,474132,184113,22329,38314,80818,34120,6755,0241,5875,449028,90310,81310,416
   Common Stock
10,000
11,228
11,926
12,780
13,167
14,174
17,107
33,932
33,934
34,750
39,701
134,731
145,306
154,608
161,544
170,316
176,905
176,905
209,546
209,861
209,895
228,100
228,100
228,100
231,274
232,632
232,632
232,778
237,602
237,529
244,606
244,606237,529237,602232,778232,632232,632231,274228,100228,100228,100209,895209,861209,546176,905176,905170,316161,544154,608145,306134,73139,70134,75033,93433,93217,10714,17413,16712,78011,92611,22810,000
   Retained Earnings 
416
-570
-5,143
-7,974
-8,725
-12,586
-12,083
-13,257
-18,623
-22,971
-25,633
-25,751
-41,028
-47,154
-56,042
-147,248
-155,749
-167,024
-165,918
-176,973
-199,038
-209,243
-229,363
-246,677
-255,222
-259,149
-256,026
-230,848
-234,254
-264,104
-239,628
-239,628-264,104-234,254-230,848-256,026-259,149-255,222-246,677-229,363-209,243-199,038-176,973-165,918-167,024-155,749-147,248-56,042-47,154-41,028-25,751-25,633-22,971-18,623-13,257-12,083-12,586-8,725-7,974-5,143-570416
   Capital Surplus 0000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000
   Other Stockholders Equity 
0
155
22,120
0
1,007
0
2
13
3,077
0
0
0
0
0
0
0
0
0
0
0
0
0
30,191
30,224
30,352
30,416
28,153
28,537
29,002
25
0
02529,00228,53728,15330,41630,35230,22430,19100000000000003,07713201,007022,1201550



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue474
Cost of Revenue-696
Gross Profit-222-222
 
Operating Income (+$)
Gross Profit-222
Operating Expense-4,367
Operating Income-4,589-4,589
 
Operating Expense (+$)
Research Development2,117
Selling General Administrative3,078
Selling And Marketing Expenses829
Operating Expense4,3676,024
 
Net Interest Income (+$)
Interest Income36
Interest Expense-15
Other Finance Cost-0
Net Interest Income20
 
Pretax Income (+$)
Operating Income-4,589
Net Interest Income20
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,512-4,666
EBIT - interestExpense = -4,605
-4,512
-3,421
Interest Expense15
Earnings Before Interest and Taxes (EBIT)-4,589-4,497
Earnings Before Interest and Taxes (EBITDA)-4,411
 
After tax Income (+$)
Income Before Tax-4,512
Tax Provision-0
Net Income From Continuing Ops-3,437-4,512
Net Income-3,437
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,063
Total Other Income/Expenses Net77-20
 

Technical Analysis of Avecho
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Avecho. The general trend of Avecho is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Avecho's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Avecho Biotechnology Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.005 < 0.005 < 0.005.

The bearish price targets are: 0.004 > 0.004 > 0.004.

Tweet this
Avecho Biotechnology Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Avecho Biotechnology Ltd. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Avecho Biotechnology Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Avecho Biotechnology Ltd. The current macd is 0.00012754.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Avecho price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Avecho. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Avecho price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Avecho Biotechnology Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAvecho Biotechnology Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Avecho Biotechnology Ltd. The current adx is 29.07.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Avecho shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Avecho Biotechnology Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Avecho Biotechnology Ltd. The current sar is 0.00369149.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Avecho Biotechnology Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Avecho Biotechnology Ltd. The current rsi is 54.83. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Avecho Biotechnology Ltd Daily Relative Strength Index (RSI) ChartAvecho Biotechnology Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Avecho Biotechnology Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Avecho price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Avecho Biotechnology Ltd Daily Stochastic Oscillator ChartAvecho Biotechnology Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Avecho Biotechnology Ltd. The current cci is 53.76.

Avecho Biotechnology Ltd Daily Commodity Channel Index (CCI) ChartAvecho Biotechnology Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Avecho Biotechnology Ltd. The current cmo is 12.83.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Avecho Biotechnology Ltd Daily Chande Momentum Oscillator (CMO) ChartAvecho Biotechnology Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Avecho Biotechnology Ltd. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Avecho Biotechnology Ltd Daily Williams %R ChartAvecho Biotechnology Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Avecho Biotechnology Ltd.

Avecho Biotechnology Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Avecho Biotechnology Ltd. The current atr is 0.00078184.

Avecho Biotechnology Ltd Daily Average True Range (ATR) ChartAvecho Biotechnology Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Avecho Biotechnology Ltd. The current obv is 50,264,519.

Avecho Biotechnology Ltd Daily On-Balance Volume (OBV) ChartAvecho Biotechnology Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Avecho Biotechnology Ltd. The current mfi is 24.29.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Avecho Biotechnology Ltd Daily Money Flow Index (MFI) ChartAvecho Biotechnology Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Avecho Biotechnology Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Avecho Biotechnology Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Avecho Biotechnology Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.829
Ma 20Greater thanMa 500.004
Ma 50Greater thanMa 1000.004
Ma 100Greater thanMa 2000.004
OpenGreater thanClose0.004
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Avecho with someone you think should read this too:
  • Are you bullish or bearish on Avecho? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Avecho? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Avecho Biotechnology Ltd

I send you an email if I find something interesting about Avecho Biotechnology Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Avecho Biotechnology Ltd.

Receive notifications about Avecho Biotechnology Ltd in your mailbox!